NewAmsterdam Pharma NAMS
NASDAQ NAMS
$20.65 +1.47 (+7.66%)
As of: Nov 11, 2026 · 2:31 PM EST

NewAmsterdam Pharma (NAMS) Long-Term Investments (2025 - 2026)

Updated

Analysis

NewAmsterdam Pharma (NAMS) Long-Term Investments (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 387.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 63.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 268.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.45 Bn
10 NewAmsterdam Pharma 2.30 Bn -236.30 Mn - 14.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 14.88 Mn
Jun 30, 2026 44.41 Mn
Mar 31, 2026 71.24 Mn
Dec 31, 2025 92.61 Mn
Sep 30, 2025 53.09 Mn
Jun 30, 2025 44.17 Mn
API Access

NewAmsterdam Pharma Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=NAMS&period=max&api_key=YOUR_API_KEY